Russia Completes Clinical Trials Of Second Potential COVID-19 Vaccine

Russia completes clinical trials of second potential COVID-19 vaccine

MOSCOW, (UrduPoint / Pakistan Point News / WAM - 30th Sep, 2020) Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.

The institute completed early-stage human trials, known as Phase II, earlier this month.

Related Topics